⌘K

Login Start Free

Home/Filings/4/0001493152-22-023389

4//SEC Filing

Ross Douglas T. 4

Accession 0001493152-22-023389

CIK 0001642380other

View on SEC.gov Company Profile

Filed

Aug 16, 8:00 PM ET

Accepted

Aug 17, 8:24 PM ET

Size

4.8 KB

Accession

0001493152-22-023389

Insider Transaction Report

Form 4

Period: 2022-08-15

Oncocyte CorpOCX

Ross Douglas T.

CMO

Transactions

Award
Common Stock, no par value
2022-08-15+150,000→ 170,317 total

Footnotes (1)

[F1]The Restricted Stock Units shall vest on January 1, 2024 based on the achievement of a pre-determined financial objective related to the Issuer's available cash.

Documents

1 file

4
ownership.xmlPrimary

Issuer

Oncocyte Corp

CIK 0001642380

Entity typeother

Related Parties

1

filerCIK 0001808413

Filing Metadata

Form type: 4
Filed: Aug 16, 8:00 PM ET
Accepted: Aug 17, 8:24 PM ET
Size: 4.8 KB

View on SEC.gov